First-in-human uPAR PET: Imaging of Cancer Aggressiveness

A first-in-human clinical trial with Positron Emission Tomography (PET) imaging of the urokinase-type plasminogen activator receptor (uPAR) in patients with breast, prostate and bladder cancer, is described. uPAR is expressed in many types of human cancers and the expression is predictive of invasio...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Morten, Skovgaard, Dorthe, Brandt-Larsen, Malene, Christensen, Camilla, Madsen, Jacob, Nielsen, Carsten H., Thurison, Tine, Klausen, Thomas Levin, Holm, Søren, Loft, Annika, Berthelsen, Anne Kiil, Ploug, Michael, Pappot, Helle, Brasso, Klaus, Kroman, Niels, Højgaard, Liselotte, Kjaer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615734/
https://www.ncbi.nlm.nih.gov/pubmed/26516369
http://dx.doi.org/10.7150/thno.12956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615734/
https://www.ncbi.nlm.nih.gov/pubmed/26516369
http://dx.doi.org/10.7150/thno.12956

Ejemplares similares